BeiGene Historical Income Statement

BGNE Stock  USD 131.86  2.19  1.63%   
Historical analysis of BeiGene income statement accounts such as Interest Expense of 39.2 M, Selling General Administrative of 1.5 B or Total Revenue of 2.6 B can show how well BeiGene performed in making a profits. Evaluating BeiGene income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of BeiGene's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining BeiGene latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether BeiGene is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

About BeiGene Income Statement Analysis

BeiGene Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to BeiGene shareholders. The income statement also shows BeiGene investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

BeiGene Income Statement Chart

BeiGene Income Statement is one of the three primary financial statements used for reporting BeiGene's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of BeiGene revenue and expense. BeiGene Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, BeiGene's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.5 B, whereas Net Loss is forecasted to decline to (1 B).

Total Revenue

Total revenue comprises all receipts BeiGene generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BeiGene. It is also known as BeiGene overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most accounts from BeiGene's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 1.5 B, whereas Net Loss is forecasted to decline to (1 B).
 2021 2022 2023 2024 (projected)
Total Operating Expenses990.9M1.3B3.2B3.4B
Cost Of Revenue1.6B1.9B463.9M755.2M

BeiGene income statement Correlations

0.620.710.860.930.69-0.32-0.22-0.32-0.09-0.310.030.93-0.150.95-0.180.79-0.30.780.870.270.820.54-0.95
0.620.70.720.530.67-0.48-0.48-0.48-0.12-0.470.330.71-0.430.38-0.460.9-0.250.90.920.240.890.5-0.59
0.710.70.960.510.99-0.85-0.81-0.85-0.16-0.840.690.92-0.770.56-0.780.68-0.530.680.810.640.890.91-0.69
0.860.720.960.730.94-0.67-0.61-0.67-0.14-0.670.470.98-0.550.73-0.580.79-0.450.790.880.490.910.81-0.83
0.930.530.510.730.46-0.010.08-0.01-0.020.0-0.260.790.150.890.120.79-0.230.780.76-0.020.660.29-0.89
0.690.670.990.940.46-0.89-0.84-0.89-0.17-0.880.730.91-0.80.56-0.820.64-0.50.640.790.690.880.93-0.67
-0.32-0.48-0.85-0.67-0.01-0.890.991.00.181.0-0.94-0.620.98-0.210.99-0.30.46-0.31-0.5-0.82-0.66-0.910.31
-0.22-0.48-0.81-0.610.08-0.840.990.990.180.99-0.97-0.541.0-0.081.0-0.270.44-0.27-0.45-0.79-0.61-0.870.22
-0.32-0.48-0.85-0.67-0.01-0.891.00.990.181.0-0.93-0.620.98-0.210.99-0.30.46-0.31-0.5-0.82-0.66-0.910.31
-0.09-0.12-0.16-0.14-0.02-0.170.180.180.180.18-0.17-0.130.17-0.060.17-0.050.29-0.05-0.1-0.17-0.12-0.180.07
-0.31-0.47-0.84-0.670.0-0.881.00.991.00.18-0.94-0.610.98-0.190.99-0.290.46-0.3-0.49-0.82-0.66-0.910.31
0.030.330.690.47-0.260.73-0.94-0.97-0.93-0.17-0.940.37-0.98-0.11-0.970.09-0.340.110.260.710.430.78-0.06
0.930.710.920.980.790.91-0.62-0.54-0.62-0.13-0.610.37-0.480.82-0.510.8-0.460.80.90.490.920.78-0.89
-0.15-0.43-0.77-0.550.15-0.80.981.00.980.170.98-0.98-0.48-0.021.0-0.20.42-0.21-0.39-0.79-0.56-0.840.16
0.950.380.560.730.890.56-0.21-0.08-0.21-0.06-0.19-0.110.82-0.02-0.040.61-0.250.590.690.260.660.46-0.9
-0.18-0.46-0.78-0.580.12-0.820.991.00.990.170.99-0.97-0.511.0-0.04-0.230.43-0.24-0.42-0.79-0.58-0.860.18
0.790.90.680.790.790.64-0.3-0.27-0.3-0.05-0.290.090.8-0.20.61-0.23-0.261.00.940.150.890.49-0.77
-0.3-0.25-0.53-0.45-0.23-0.50.460.440.460.290.46-0.34-0.460.42-0.250.43-0.26-0.25-0.33-0.52-0.45-0.470.32
0.780.90.680.790.780.64-0.31-0.27-0.31-0.05-0.30.110.8-0.210.59-0.241.0-0.250.930.150.890.5-0.76
0.870.920.810.880.760.79-0.5-0.45-0.5-0.1-0.490.260.9-0.390.69-0.420.94-0.330.930.310.970.62-0.83
0.270.240.640.49-0.020.69-0.82-0.79-0.82-0.17-0.820.710.49-0.790.26-0.790.15-0.520.150.310.530.76-0.25
0.820.890.890.910.660.88-0.66-0.61-0.66-0.12-0.660.430.92-0.560.66-0.580.89-0.450.890.970.530.76-0.79
0.540.50.910.810.290.93-0.91-0.87-0.91-0.18-0.910.780.78-0.840.46-0.860.49-0.470.50.620.760.76-0.54
-0.95-0.59-0.69-0.83-0.89-0.670.310.220.310.070.31-0.06-0.890.16-0.90.18-0.770.32-0.76-0.83-0.25-0.79-0.54
Click cells to compare fundamentals

BeiGene Account Relationship Matchups

BeiGene income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization1.3M846K750K751K87.7M92.1M
Interest Expense9.1M338K(15.8M)52.5M37.4M39.2M
Selling General Administrative388.2M600.2M990.1M1.3B1.4B1.5B
Total Revenue428.2M308.9M1.2B1.4B2.5B2.6B
Gross Profit(570.3M)(1.1B)(447.9M)(511.1M)2.0B2.1B
Other Operating Expenses1.4B2.0B2.6B3.2B3.7B3.8B
Operating Income(959.9M)(1.7B)(1.4B)(1.8B)(1.2B)(1.1B)
Net Income From Continuing Ops(950.6M)(1.6B)(1.4B)(2.0B)(959.5M)(1.0B)
Ebit(959.9M)(1.7B)(1.4B)(1.8B)(1.2B)(1.1B)
Research Development927.3M1.3B1.5B1.6B1.7B1.6B
Ebitda(958.6M)(1.7B)(1.4B)(1.8B)(1.1B)(1.2B)
Cost Of Revenue998.5M1.4B1.6B1.9B463.9M755.2M
Total Operating Expenses389.6M601.0M990.9M1.3B3.2B3.4B
Income Before Tax(943.6M)(1.6B)(1.4B)(2.0B)(825.8M)(867.1M)
Total Other Income Expense Net16.3M39.5M147K(171.4M)381.9M401.0M
Net Income Applicable To Common Shares(948.6M)(1.6B)(1.4B)(2.0B)(1.8B)(1.7B)
Net Income(950.6M)(1.6B)(1.4B)(2.0B)(881.7M)(925.8M)
Income Tax Expense7.0M(17.7M)(25.2M)42.8M55.9M58.7M
Tax Provision7.0M(17.7M)(25.2M)42.8M53.5M56.1M
Net Interest Income9.1M2.0M(15.8M)52.5M76.0M79.8M
Non Operating Income Net Other2.0M7.2M37.5M15.9M18.3M13.7M
Reconciled Depreciation18.6M31.8M750K66.3M81.9M86.0M

Pair Trading with BeiGene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BeiGene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will appreciate offsetting losses from the drop in the long position's value.

Moving together with BeiGene Stock

  0.71JNJ Johnson Johnson Financial Report 18th of July 2024 PairCorr

Moving against BeiGene Stock

  0.43EWTX Edgewise Therapeutics Downward RallyPairCorr
The ability to find closely correlated positions to BeiGene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BeiGene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BeiGene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BeiGene to buy it.
The correlation of BeiGene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BeiGene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BeiGene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BeiGene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether BeiGene is a strong investment it is important to analyze BeiGene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BeiGene's future performance. For an informed investment choice regarding BeiGene Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for BeiGene Stock analysis

When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.45)
Revenue Per Share
23.554
Quarterly Revenue Growth
0.669
Return On Assets
(0.12)
Return On Equity
(0.22)
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.